dementia
HIV drug holds hope for Alzheimer’s after significantly reducing inflammation in mice
February 7, 2019Research and Development HIV, dementia, inflamation
Lamivudine, a generic drug for HIV, significantly reduces age-related inflammation and other signs of aging in mice, according to a …
UK Dementia partnership offering £100,000-200,000 awards for dementia research projects
October 23, 2018Manufacturing and Production Alzheimer's, dementia, development, research
The Dementia Discovery Fund (DDF) in partnership with the UK Dementia Research Institute (UK DRI) has announced that it will …
Top Ten most popular articles on Pharmafile.com this week
October 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10
As September came to a close and October began the UK was hit hard in the headlines after American firm …
Living with childhood dementia
June 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing childhood dementia, dementia, feature, patient experience, pharma
Claire Young explores her family’s journey through the diagnosis of her son George, who lives with Batten disease, a form …
Top Ten most popular articles on Pharmafile.com this week
May 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, EMA, Kymriah, Novartis, Porton Biopharma, Regeneron, Roche, Sandoz, Sanofi, Shire, Takeda, biosimilars, dementia
It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …
New study argues the importance of existing anti-inflammatory drugs in fighting dementia
May 3, 2018Research and Development Alzheimer's, dementia, pharma
Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal …
Common antidepressants linked to dementia risk
April 26, 2018Medical Communications anticholinergic, biotech, dementia, drugs, pharma, pharmaceutical
A large study looking at the public’s use of anticholinergic drugs, such as those used to treat depression and Parkinson’s, …
Antiepileptic drug use linked to increased risk of Alzheimer’s and dementia
April 10, 2018Manufacturing and Production, Research and Development Alzheimer's disease, dementia, epilepsy, pharma
A new study conducted at the University of Eastern Finland and the German Center for Neurodegenerative Diseases (DZNE) has revealed …
Boehringer terminates Alzheimer’s candidate after Phase 2 failure
February 12, 2018Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma
Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …
Axovant’s drug bested by placebo, shares reduced to dust
January 8, 2018Manufacturing and Production, Research and Development Axovant, Roivant, biotech, dementia, drugs, pharma, pharmaceutical
The signs were already there for Axovant Sciences’ key drug, intepirdine, when it posted poor results from a recent study …
‘Brain training’ found to reduce risk of dementia by 29%
November 22, 2017Research and Development biotech, dementia, drugs, pharma, pharmaceutical
In a 10-year study conducted at the Indiana University School of Medicine, researchers were able to observe a 29% reduced …
Over-the-counter multinutrient drink could have beneficial impact on Alzheimer’s, new study reveals
October 31, 2017Manufacturing and Production, Research and Development Alzheimer's, Fortasyn Connect, Souvenaid, dementia
LipiDiDiet, a European project investigating “the impact of nutritional lipids on neuronal and cognitive performance in ageing, Alzheimer’s disease and …
Research finds blood-thinners protect against dementia
October 25, 2017Research and Development Alzheimer's, anticoagulant, biotech, dementia, drugs, pharma, pharmaceutical
Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …
Alzheimer’s disease: Fighting back against a growing threat
September 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's UK, dementia, life sciences, pharma
September marks Alzheimer’s Awareness Month, a crucial calendar period as the global threat of the disease slowly grows. To mark …
Stomach acid drugs do not increase Alzheimer’s risk, study confirms
August 7, 2017Research and Development, Sales and Marketing Alzheimer's, dementia, drugs, healthcare, lansoprazole, life sciences, medicine, omeprazole, pharma, pharmaceuticals, proton pump inhibitors
A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
